Type 2 diabetes affects millions of people worldwide and now a new international study, jointly led by Adelaide University, ...
Bank of America Global Healthcare Conference 2026 May 12, 2026 5:20 PM EDTCompany ParticipantsSusan Morrison - ...
Antidiabetic drug classes show varied associations with liver outcomes in T2DM, with SGLT2 inhibitors and GLP-1 RA ranking highest.
The question is no longer whether mental health belongs in health care settings. It is whether health care systems can ...
Virginia Gov. Abigail Spanberger signed health care cost-cutting bills into law Wednesday in Fairfax County, aiming to make ...
A high-touch specialty pharmacy program that combines pharmacist support, telehealth and value-based care reduced medical costs and improved outcomes for patients with diabetes, according to ...
Americans' voracious appetite for GLP-1 weight loss drugs has the nation on pace to spend more than $1 trillion on ...
Hosted on MSN
GLP-1 drugs are changing more than diabetes care
GLP-1 medications, originally developed for type 2 diabetes and weight loss, are now approved for multiple chronic conditions and being studied for many more. From heart disease and sleep apnea to ...
GLP-1 gains in T1D: Two adolescents with type 1 diabetes and obesity saw weight loss, reduced insulin use, and better glucose control after adding semaglutide to lifestyle changes. Metformin’s gut ...
A blanket refusal to cover weight-loss medication like GLP-1s is no longer allowed under Washington state law, an appeals ...
High costs have made employers and insurers weary, but patients who can be treated for obesity are increasingly being left in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results